Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 43 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10588943

    Glucokinase activator compositions for the treatment of diabetes

    VTV THERAPEUTICS LLC · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  2. US 10588940

    Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  3. US 10583148

    Methods and devices for bone infection treatment selection

    The United States Government · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  4. US 10576095

    Use of aminoglycoside analogs in the treatment of Rett syndrome

    ELOXX PHARMACEUTICALS LTD. · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  5. US 10576099

    Injectable scaffold for treatment of intracranial aneurysms and related technology

    Covidien LP · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  6. US 10576079

    Multi-drug therapies for tuberculosis treatment

    The Regents of the University of California · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

  7. US 10570115

    Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  8. US 10570183

    Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  9. US 10568901

    Micro-RNA for the treatment of malignant solid tumors and metastasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  10. US 10570214

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  11. US 10562975

    CD6 antibody for treatment of T-cell mediated diseases or disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  12. US 10563259

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  13. US 10562882

    Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

    Takeda Pharmaceutical Company Limited · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  14. US 10557118

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  15. US 10555942

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  16. US 10555929

    Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

    Coherus BioSciences, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  17. US 10555960

    Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  18. US 10555963

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  19. US 10548886

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  20. US 10548916

    Composition comprising neoagarooligosaccharide as active ingredient, for prevention or treatment of sepsis or septic shock

    DYNEBIO INC. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  21. US 10550129

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  22. US 10550193

    Methods and antibody compositions for tumor treatment

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  23. US 10543181

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jan 28, 2020 · Expires Jan 23, 2040

    granted

  24. US 10537560

    P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

    Fulcrum Therapeutics, Inc. · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.